You are here: / Recherche et université / Nos publications /¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.
Contactez-nous
Standard Brest
02 98 22 33 33
Standard Carhaix
02 98 99 20 20
Urgences
15
Urgences adultes
02 98 34 74 55
Urgences pédiatriques
02 98 22 33 33